![](/img/cover-not-exists.png)
Prevention of Aromatase Inhibitor-Induced Bone Loss Using Risedronate: The SABRE Trial
Van Poznak, C., Hannon, R. A., Mackey, J. R., Campone, M., Apffelstaedt, J. P., Clack, G., Barlow, D., Makris, A., Eastell, R.Volume:
28
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2009.24.5902
Date:
February, 2010
File:
PDF, 290 KB
english, 2010